Cargando…
Preventive healthcare policies in the US: solutions for disease management using Big Data Analytics
Data-driven healthcare policy discussions are gaining traction after the Covid-19 outbreak and ahead of the 2020 US presidential elections. The US has a hybrid healthcare structure; it is a system that does not provide universal coverage, albeit few years ago enacted a mandate (Affordable Care Act-A...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7309216/ https://www.ncbi.nlm.nih.gov/pubmed/32834926 http://dx.doi.org/10.1186/s40537-020-00315-8 |
_version_ | 1783549170151325696 |
---|---|
author | Batarseh, Feras A. Ghassib, Iya Chong, Deri (Sondor) Su, Po-Hsuan |
author_facet | Batarseh, Feras A. Ghassib, Iya Chong, Deri (Sondor) Su, Po-Hsuan |
author_sort | Batarseh, Feras A. |
collection | PubMed |
description | Data-driven healthcare policy discussions are gaining traction after the Covid-19 outbreak and ahead of the 2020 US presidential elections. The US has a hybrid healthcare structure; it is a system that does not provide universal coverage, albeit few years ago enacted a mandate (Affordable Care Act-ACA) that provides coverage for the majority of Americans. The US has the highest health expenditure per capita of all western and developed countries; however, most Americans don’t tap into the benefits of preventive healthcare. It is estimated that only 8% of Americans undergo routine preventive screenings. On a national level, very few states (15 out of the 50) have above-average preventive healthcare metrics. In literature, many studies focus on the cure of diseases (research areas such as drug discovery and disease prediction); whilst a minority have examined data-driven preventive measures—a matter that Americans and policy makers ought to place at the forefront of national issues. In this work, we present solutions for preventive practices and policies through Machine Learning (ML) methods. ML is morally neutral, it depends on the data that train the models; in this work, we make the case that Big Data is an imperative paradigm for healthcare. We examine disparities in clinical data for US patients by developing correlation and imputation methods for data completeness. Non-conventional patterns are identified. The data lifecycle followed is methodical and deliberate; 1000+ clinical, demographical, and laboratory variables are collected from the Centers for Disease Control and Prevention (CDC). Multiple statistical models are deployed (Pearson correlations, Cramer’s V, MICE, and ANOVA). Other unsupervised ML models are also examined (K-modes and K-prototypes for clustering). Through the results presented in the paper, pointers to preventive chronic disease tests are presented, and the models are tested and evaluated. |
format | Online Article Text |
id | pubmed-7309216 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-73092162020-06-23 Preventive healthcare policies in the US: solutions for disease management using Big Data Analytics Batarseh, Feras A. Ghassib, Iya Chong, Deri (Sondor) Su, Po-Hsuan J Big Data Research Data-driven healthcare policy discussions are gaining traction after the Covid-19 outbreak and ahead of the 2020 US presidential elections. The US has a hybrid healthcare structure; it is a system that does not provide universal coverage, albeit few years ago enacted a mandate (Affordable Care Act-ACA) that provides coverage for the majority of Americans. The US has the highest health expenditure per capita of all western and developed countries; however, most Americans don’t tap into the benefits of preventive healthcare. It is estimated that only 8% of Americans undergo routine preventive screenings. On a national level, very few states (15 out of the 50) have above-average preventive healthcare metrics. In literature, many studies focus on the cure of diseases (research areas such as drug discovery and disease prediction); whilst a minority have examined data-driven preventive measures—a matter that Americans and policy makers ought to place at the forefront of national issues. In this work, we present solutions for preventive practices and policies through Machine Learning (ML) methods. ML is morally neutral, it depends on the data that train the models; in this work, we make the case that Big Data is an imperative paradigm for healthcare. We examine disparities in clinical data for US patients by developing correlation and imputation methods for data completeness. Non-conventional patterns are identified. The data lifecycle followed is methodical and deliberate; 1000+ clinical, demographical, and laboratory variables are collected from the Centers for Disease Control and Prevention (CDC). Multiple statistical models are deployed (Pearson correlations, Cramer’s V, MICE, and ANOVA). Other unsupervised ML models are also examined (K-modes and K-prototypes for clustering). Through the results presented in the paper, pointers to preventive chronic disease tests are presented, and the models are tested and evaluated. Springer International Publishing 2020-06-23 2020 /pmc/articles/PMC7309216/ /pubmed/32834926 http://dx.doi.org/10.1186/s40537-020-00315-8 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Research Batarseh, Feras A. Ghassib, Iya Chong, Deri (Sondor) Su, Po-Hsuan Preventive healthcare policies in the US: solutions for disease management using Big Data Analytics |
title | Preventive healthcare policies in the US: solutions for disease management using Big Data Analytics |
title_full | Preventive healthcare policies in the US: solutions for disease management using Big Data Analytics |
title_fullStr | Preventive healthcare policies in the US: solutions for disease management using Big Data Analytics |
title_full_unstemmed | Preventive healthcare policies in the US: solutions for disease management using Big Data Analytics |
title_short | Preventive healthcare policies in the US: solutions for disease management using Big Data Analytics |
title_sort | preventive healthcare policies in the us: solutions for disease management using big data analytics |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7309216/ https://www.ncbi.nlm.nih.gov/pubmed/32834926 http://dx.doi.org/10.1186/s40537-020-00315-8 |
work_keys_str_mv | AT batarsehferasa preventivehealthcarepoliciesintheussolutionsfordiseasemanagementusingbigdataanalytics AT ghassibiya preventivehealthcarepoliciesintheussolutionsfordiseasemanagementusingbigdataanalytics AT chongderisondor preventivehealthcarepoliciesintheussolutionsfordiseasemanagementusingbigdataanalytics AT supohsuan preventivehealthcarepoliciesintheussolutionsfordiseasemanagementusingbigdataanalytics |